138 related articles for article (PubMed ID: 10861312)
1. alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Melbye M; Wohlfahrt J; Lei U; Nørgaard-Pedersen B; Mouridsen HT; Lambe M; Michels KB
J Natl Cancer Inst; 2000 Jun; 92(12):1001-5. PubMed ID: 10861312
[TBL] [Abstract][Full Text] [Related]
2. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk.
Richardson BE; Hulka BS; Peck JL; Hughes CL; van den Berg BJ; Christianson RE; Calvin JA
Am J Epidemiol; 1998 Oct; 148(8):719-27. PubMed ID: 9786226
[TBL] [Abstract][Full Text] [Related]
3. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1).
Krause TG; Christens P; Wohlfahrt J; Lei U; Westergaard T; Nørgaard-Pedersen B; Melbye M
Obstet Gynecol; 2001 Feb; 97(2):277-82. PubMed ID: 11165595
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
Lukanova A; Andersson R; Wulff M; Zeleniuch-Jacquotte A; Grankvist K; Dossus L; Afanasyeva Y; Johansson R; Arslan AA; Lenner P; Wadell G; Hallmans G; Toniolo P; Lundin E
Am J Epidemiol; 2008 Dec; 168(11):1284-91. PubMed ID: 18936438
[TBL] [Abstract][Full Text] [Related]
5. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Richardson BE; Peck JD; Wormuth JK
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1349-55. PubMed ID: 11142421
[TBL] [Abstract][Full Text] [Related]
6. Beyond the twinning effect: invited commentary on "Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk".
Thompson WD
Am J Epidemiol; 1998 Oct; 148(8):728-9; discussion 730-1. PubMed ID: 9786227
[No Abstract] [Full Text] [Related]
7. Birth weight, breast cancer and the potential mediating hormonal environment.
Bukowski R; Chlebowski RT; Thune I; Furberg AS; Hankins GD; Malone FD; D'Alton ME
PLoS One; 2012; 7(7):e40199. PubMed ID: 22815728
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in breast cancer risk: a possible role for pregnancy levels of alpha-fetoprotein?
Lambe M; Trichopoulos D; Hsieh CC; Wuu J; Adami HO; Wide L
Epidemiology; 2003 Jan; 14(1):85-9. PubMed ID: 12500052
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
Waller DK; Lustig LS; Cunningham GC; Golbus MS; Hook EB
N Engl J Med; 1991 Jul; 325(1):6-10. PubMed ID: 1710779
[TBL] [Abstract][Full Text] [Related]
10. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
13. Risk of breast cancer among young women: relationship to induced abortion.
Daling JR; Malone KE; Voigt LF; White E; Weiss NS
J Natl Cancer Inst; 1994 Nov; 86(21):1584-92. PubMed ID: 7932822
[TBL] [Abstract][Full Text] [Related]
14. Hypertension, pregnancy, and risk of breast cancer.
Thompson WD; Jacobson HI; Negrini B; Janerich DT
J Natl Cancer Inst; 1989 Oct; 81(20):1571-4. PubMed ID: 2477555
[TBL] [Abstract][Full Text] [Related]
15. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
17. Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
Lei U; Wohlfahrt J; Christens P; Westergaard T; Lambe M; Nørgaard-Pedersen B; Melbye M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1147-51. PubMed ID: 15548147
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
19. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
20. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study.
Colditz GA; Willett WC; Hunter DJ; Stampfer MJ; Manson JE; Hennekens CH; Rosner BA
JAMA; 1993 Jul; 270(3):338-43. PubMed ID: 8123079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
